Current and emerging therapy of dry eye disease. Part A: pharmacological modalities

Nariman NassiriKresge Eye Institute - Department of Ophthalmology, School of Medicine, Wayne State University, Detroit, MI, USAView further author information

Yasaira Rodriguez TorresKresge Eye Institute - Department of Ophthalmology, School of Medicine, Wayne State University, Detroit, MI, USAView further author information

Zachary MeyerKresge Eye Institute - Department of Ophthalmology, School of Medicine, Wayne State University, Detroit, MI, USAView further author information

Michael A. BeyerKresge Eye Institute - Department of Ophthalmology, School of Medicine, Wayne State University, Detroit, MI, USAView further author information

Gautham VellaichamyKresge Eye Institute - Department of Ophthalmology, School of Medicine, Wayne State University, Detroit, MI, USAView further author information

Amar S. DhaliwalKresge Eye Institute - Department of Ophthalmology, School of Medicine, Wayne State University, Detroit, MI, USAView further author information

Neil ChungfatDepartment of Ophthalmology, School of Medicine, University of North Carolina, Chapel Hill, NC, USAView further author information

Frank S. HwangKresge Eye Institute - Department of Ophthalmology, School of Medicine, Wayne State University, Detroit, MI, USACorrespondence[email protected]

http://orcid.org/0000-0002-9462-9648 View further author information

show all

Current and emerging therapy of dry eye disease. Part A: pharmacological modalities

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Current and emerging therapy of dry eye disease. Part A: pharmacological modalities

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date